Philippines Health News API

{
    "totalArticles": 104920,
    "articles": [
        {
            "id": "fa60a4b071b94928e39838e35a65c239",
            "title": "AI Tool Developed at University of Leicester Assesses Secondary Heart Attack Risk in Cancer Patients",
            "description": "Researchers at the University of Leicester have develop […]",
            "content": "Researchers at the University of Leicester have developed an Artificial Intelligence-based tool designed to evaluate the risk of secondary heart attacks in cancer patients. The tool aims to address the complex challenge of managing cardiovascular hea... [982 chars]",
            "url": "https://www.geneonline.com/ai-tool-developed-at-university-of-leicester-assesses-secondary-heart-attack-risk-in-cancer-patients/",
            "image": "https://www.geneonline.com/wp-content/uploads/EN_NEWSFLASH_5-1.png",
            "publishedAt": "2026-02-01T20:33:46Z",
            "lang": "en",
            "source": {
                "id": "e5376462a7128acdb762718aa2daf90e",
                "name": "geneonline.com",
                "url": "https://www.geneonline.com"
            }
        },
        {
            "id": "88c429528388aa360ad104ddfe994114",
            "title": "Study Finds Males in the U.S. Have 63 Percent Higher All",
            "description": "A recent cohort study utilizing data from 47,000 adults […]",
            "content": "Study Finds Males in the U.S. Have 63 Percent Higher All-Cause Mortality Risk Than Females\nA recent cohort study utilizing data from 47,000 adults in the National Health and Nutrition Examination Survey has identified a notable disparity in all-cause... [1097 chars]",
            "url": "https://www.geneonline.com/study-finds-males-in-the-u-s-have-63-percent-higher-all-cause-mortality-risk-than-females/",
            "image": "https://www.geneonline.com/wp-content/uploads/EN_NEWSFLASH_5-1.png",
            "publishedAt": "2026-02-01T20:04:45Z",
            "lang": "en",
            "source": {
                "id": "e5376462a7128acdb762718aa2daf90e",
                "name": "geneonline.com",
                "url": "https://www.geneonline.com"
            }
        },
        {
            "id": "3d4e227a0c23111e755294882ca50db9",
            "title": "Free Survival vs Overall Survival: Which Matters More?",
            "description": "Progression-Free Survival vs Overall Survival explained: how PFS and OS differ, what they measure, and why each matters in oncology trials and patient care.",
            "content": "When new cancer treatments are discussed, whether in clinical trials, regulatory approvals, or patient consultations, two outcome measures appear repeatedly: progression-free survival (PFS) and overall survival (OS). These endpoints are central to ho... [8874 chars]",
            "url": "https://oncodaily.com/oncolibrary/progression-free-survival-vs-overall-survival",
            "image": "https://oncodaily.com/pub/uploads/2026/02/IMG_4014.webp",
            "publishedAt": "2026-02-01T18:57:34Z",
            "lang": "en",
            "source": {
                "id": "654c15cf5fba9c885b59fdc406129149",
                "name": "Oncodaily",
                "url": "https://oncodaily.com"
            }
        }
    ]
}